Advantages of Fetal Stem Cell Treatment
Fetal stem cell treatment has a number of advantages compared to transplantation of any other type of stem cells, i.e. adult, cord blood and animal stem cells.
Fetal stem cell treatment allows avoiding histocompatibility problems
Histocompatibility has always been regarded as stumbling-block of transplantology, causing rejection of transplanted organs, bone marrow and cord blood stem cells, etc., thus requiring special measures aimed at suppression of the recipient's immune system. With fetal stem cell transplantation, it is possible to avoid any side effects related to histocompatibility and ensure engraftment and proliferation of the administered cells, as well as their functioning in the body for many months and even years without immunosuppression.
Fetal stem cell treatment ensures both target and systemic effects
In addition to targeted cell effects predicted and described by numerous researchers, fetal stem cell transplantation can exert powerful systemic effects related to psychoemotional sphere, physical activity, immune system, homeostasis and functioning of internal organs, achieved via regulatory systems of the recipient's body.
Application of different types of fetal stem cells allows achieving desirable clinical effects
Each type of stem cells produces certain specific effects. Human regulatory systems, controlling the transplanted cells, guide the development and specialization of those cells in compliance with body needs, thereby ensuring precise specialization of clinical effects.
No bioengineering methods are applied in fetal stem cell transplantation
We use only natural tissues without interference with genetic engineering (cloning) or cell culture methods.
Fetal stem cell treatment effects last for months or years
Duration of fetal stem cell treatment curative effects is not comparable with that of most medicinal preparations. Within 1–2 months after transplantation, observed are early clinical effects of fetal stem cell transplantation followed by long-term effects (from 6–8 months to 2–3 years). In some diseases, engraftment stays for the lifetime period.
Examination and treatment usually take 2–5 days
Treatment is carried out on inpatient and outpatient basis, each particular case taken into consideration. Fetal stem cell transplantation does not differ much from administration of regular medicinal preparations, thus making this procedure minimally invasive.
Fetal stem cell treatment has very few contraindications
Contraindications include: bacterial arthritis; vasculitis in active phase, capilaritis, phlebitis; severe pulmonary hypertension associated with vasculitis or thrombosis; multi-lobe pneumonia with the development of acute or subacute cor pulmonale; ophthalmopathy, retinal haemorrhage (treatment is possible in 2–3 months); myelocarcinosis, myelofibrosis, terminal stages of the disease (severe intoxication, profound metabolic disorders, severe systemic decompensations).